BioLife Solutions Inc
NASDAQ:BLFS

Watchlist Manager
BioLife Solutions Inc Logo
BioLife Solutions Inc
NASDAQ:BLFS
Watchlist
Price: 21.57 USD 0.94%
Market Cap: 1B USD

Relative Value

The Relative Value of one BLFS stock under the Base Case scenario is 8.87 USD. Compared to the current market price of 21.57 USD, BioLife Solutions Inc is Overvalued by 59%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLFS Relative Value
Base Case
8.87 USD
Overvaluation 59%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
8
Median 3Y
6.3
Median 5Y
9.9
Industry
2.2
Forward
10.3
vs History
vs Industry
1
Median 3Y
-11.9
Median 5Y
-10.8
Industry
21.7
Forward
-218.7
vs History
36
vs Industry
1
Median 3Y
-59.9
Median 5Y
-57.3
Industry
13.9
vs History
vs Industry
Median 3Y
-115.5
Median 5Y
-115.5
Industry
19.7
vs History
53
vs Industry
24
Median 3Y
2.5
Median 5Y
3
Industry
2.1
vs History
47
vs Industry
9
Median 3Y
6.3
Median 5Y
9.7
Industry
2.3
Forward
9.4
vs History
74
vs Industry
9
Median 3Y
17.9
Median 5Y
19.4
Industry
4.8
vs History
14
vs Industry
0
Median 3Y
-29.6
Median 5Y
-22.6
Industry
11.4
Forward
45
vs History
vs Industry
Median 3Y
-22.8
Median 5Y
-22.6
Industry
15.4
Forward
-140.1
vs History
36
vs Industry
2
Median 3Y
-59.7
Median 5Y
-56.6
Industry
13.7
vs History
19
vs Industry
1
Median 3Y
-33.5
Median 5Y
-36.9
Industry
17.2
vs History
49
vs Industry
21
Median 3Y
2.3
Median 5Y
3.1
Industry
1.8

Multiples Across Competitors

BLFS Competitors Multiples
BioLife Solutions Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
BioLife Solutions Inc
NASDAQ:BLFS
1B USD 10.9 -98.5 262.4 -224.4
CH
Alcon AG
SIX:ALC
34.7B CHF 4.3 38.6 17.7 33.5
JP
Hoya Corp
TSE:7741
5.8T JPY 6.6 28.5 17.5 20.9
DK
Coloplast A/S
CSE:COLO B
136.1B DKK 4.9 30 17.3 20.4
US
Align Technology Inc
NASDAQ:ALGN
13.9B USD 3.5 33.6 16.2 19.9
UK
ConvaTec Group PLC
LSE:CTEC
5.9B GBP 3.6 42.7 210.6 344.4
CH
Ypsomed Holding AG
SIX:YPSN
5.7B CHF 7.5 64.1 31.2 53.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45B CNY 12.8 32.3 27.9 27.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.6B USD 3.6 22 10.2 11.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.5B USD 3.9 44.8 20.7 36.1
KR
HLB Inc
KOSDAQ:028300
6.3T KRW 84.2 -33.3 -59.1 -55.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average EV/EBITDA: 63.2
262.4
N/A N/A
CH
Alcon AG
SIX:ALC
17.7
10%
1.8
JP
Hoya Corp
TSE:7741
17.5
9%
1.9
DK
Coloplast A/S
CSE:COLO B
17.3
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
16.2
15%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
210.6
11%
19.1
CH
Ypsomed Holding AG
SIX:YPSN
31.2
31%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.9
18%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.2
21%
0.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
20.7
12%
1.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -59.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average EV/EBIT: 63.1
Negative Multiple: -224.4
N/A N/A
CH
Alcon AG
SIX:ALC
33.5
25%
1.3
JP
Hoya Corp
TSE:7741
20.9
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.4
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
19.9
17%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
344.4
22%
15.7
CH
Ypsomed Holding AG
SIX:YPSN
53.4
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.9
16%
1.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.6
22%
0.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
36.1
28%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.9 N/A N/A